New device could benefit treatment of hand injuries

Jul 07, 2009
PRIME could revolutionize the diagnosis and treatment of hand injuries and neurological disorders, specifically carpal tunnel syndrome. Credit: Rice University

A team of Rice University bioengineering students who invented a device to measure intrinsic hand muscle strength has won two prestigious honors for their patent-pending creation, PRIME. The device could revolutionize the diagnosis and treatment of hand injuries and neurological disorders, specifically carpal tunnel syndrome.

The OrthoIntrinsics team won first place and $10,000 at IShow, an innovation competition for graduate and undergraduate students sponsored by the American Society of Mechanical Engineers in Palm Desert, Calif., this June.

They were then named one of five winners in a student design competition sponsored by the National Science Foundation at the Rehabilitation Engineering and Assistive Technology Society of North America conference in New Orleans in late June. The top five, unranked, were selected from more than 60 entries.

Graduates Caterina Kaffes, Matthew Miller, Neel Shah and Shuai "Steve" Xu invented PRIME, or Peg Restrained Intrinsic Evaluator, for their senior project. They are working with the Rice Alliance, which aids early stage technology ventures, and the Jones Graduate School of Business to refine their business plan while validation of the device is under way at two leading Texas Medical Center institutions, the Methodist Hospital and Shriners Hospital for Children.

The challenge presented by Gloria Gogola, an orthopedic surgeon specializing in pediatrics, was to create a device that accurately measures intrinsic hand muscles, which allow humans to play a piano or perform any task that requires dexterity and precision.

"Twenty percent of all ER admissions are hand-related," Xu said. "Neuromuscular disorders like , Lou Gehrig's, diabetes, multiple sclerosis -- all these diseases affect the intrinsic hand muscles."

For starters, the team is honing in on carpal tunnel syndrome. "U.S. surgeons will perform over 500,000 procedures for carpal tunnel this year. We spend $2 billion per year treating this disease but up to 20 percent of all surgeries need to be redone. Our invention can be used across the spectrum of care from diagnosis to outcome measurements," Xu said.

Anybody who's ever had a checkup knows how doctors routinely test strength -- hold up a hand, push this way, push that way. The assessment is by feel, nothing quantifiable. Xu said previous devices lack the repeatability to be useful and do not adjust for small hands or unusual morphologies.

PRIME is intended to fill that gap. The device has three elements: a pegboard restraint, a force transducer enclosure and a PDA custom-programmed to capture measurements.

In a five-minute test, a doctor uses pegs to isolate a patient's individual fingers. "You wouldn't think it works as well as it does, but once you are pegged in, you can't move anything but the finger we want you to," Miller said.

A loop is fitted around the finger, and when the patient moves it, the amount of force generated is measured. "PRIME gets the peak force," Xu said. "Then the doctor can create a patient-specific file with all your information, time-stamped, and record every single measurement." PRIME integrates with existing systems in a manner compliant with the Health Information Portability and Accountability Act, better known as HIPAA, he said.

Xu hopes it will help hospitals and rehabilitation clinics compare the effectiveness of surgical interventions and diagnose neuromuscular degenerative diseases. "There's so much applicability, it's hard to pinpoint our market size," he said.

Gogola said PRIME has found a home in her clinic. "We've been using it on patients, and it's working very nicely.

"This particular student group worked extremely hard on the project, and they went above and beyond the course requirements. They took this from a concept to an actual working, clinically useful device."

Source: Rice University (news : web)

Explore further: The impact of bacteria in our guts

add to favorites email to friend print save as pdf

Related Stories

'Fluidhand': Each finger can be moved separately

Apr 22, 2008

It can hold a credit card, use a keyboard with the index finger, and lift a bag weighing up to 20 kg – the world’s first commercially available pros-thetic hand that can move each finger separately and ...

Robotic exoskeleton replaces muscle work

Feb 08, 2007

A robotic exoskeleton controlled by the wearer's own nervous system could help users regain limb function, which is encouraging news for people with partial nervous system impairment, say University of Michigan researchers.

New surgical option for wrist arthritis

Feb 14, 2009

Breaking a fall, such as a tumble on the sidewalk, with your hands and wrists is everyone's natural reflex. But, if you fall hard enough, you'll often fracture your radius bone, or even one of the smaller wrist bones and ...

High-tech bionic hand invented in England

Jul 19, 2007

The new, high-tech i-LIMB bionic hand, with five motorized fingers, will soon be sold in Britain for about $17,000, The Telegraph reported Thursday.

Recommended for you

The impact of bacteria in our guts

16 hours ago

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

17 hours ago

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

18 hours ago

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments : 0